Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
Josep Maria LlibreFederico GarciaJosé Luis BlancoEsmeralda Palmier PeláezÁlvaro Mena de CeaLuis Eduardo Lopez-CortesMarta Montero AlonsoMiguel Pascual BernáldezMelanie SchroederSilvia Esteban SánchezFelipe Rodríguez AlcántaraPublished in: HIV medicine (2024)
The prevalence of people with HIV with MDR and LTOs in Spain is very low, with approximately half of those studied not exhibiting virological suppression. Low CD4+ cell counts were associated with MDR. These findings may help address the impact and treatment needs of these patients and prevent clinical progression and transmission of MDR HIV.
Keyphrases
- multidrug resistant
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv testing
- hiv aids
- hepatitis c virus
- drug resistant
- hiv infected patients
- men who have sex with men
- gram negative
- acinetobacter baumannii
- end stage renal disease
- risk factors
- ejection fraction
- klebsiella pneumoniae
- chronic kidney disease
- newly diagnosed
- single cell
- prognostic factors
- south africa
- stem cells
- pseudomonas aeruginosa
- bone marrow
- combination therapy